Monding, Angelika G.
HRN: 27-68-45 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2025
CEFUROXIME 1.5GM (VIAL)
08/22/2025
08/22/2025
IV
1.5 Grams
PTOR
OR Prophylaxis
Checking Initial Appropriateness
08/22/2025
CEFUROXIME 1.5GM (VIAL)
08/22/2025
08/23/2025
IV
1.5gm
Q8hr X 2 Doses
Sp Pelvic Lap
Checking Initial Appropriateness
08/23/2025
CEFUROXIME 500MG (TAB)
08/23/2025
08/30/2025
ORAL
500mg
BID
S/P Ex Lap
Checking Initial Appropriateness
08/25/2025
CEFUROXIME 500MG (TAB)
08/25/2025
08/29/2025
PO
500mg
BID
SP Ex Lap
Checking Initial Appropriateness